Long-term treatment of persistent allergic rhinitis with levocetirizine - Improvements in activity and sleep items of the Rhinoconjunctivitis quality of life questionaire (RQLQ)

Allergy and Clinical Immunology International

Volumn 19, Issue 1, 2007, Pages 4-

  Klimek, Ludger ^a   Bachert, Claus ^b   Canonica, G Walter ^c   Durham, Stephen R ^d   Mullol, Joaquim ^e   Van Cauwenberge, Paul B ^b   Van Hammée, Geneviève ^f  

^a Center for Rhinology and Allergology   (Germany)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY OF GENOA   (Italy)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e HOSPITAL CLÍNIC   (Spain)

^f UCB PHARMA   (Belgium)

Author keywords

Levocetirizine; Persitent allergic rhinitis (PER); Rhinoconjunctivitis Quality of Life Questionaire (RQLQ); Usual daily activities; XPERT

Indexed keywords

CROMOGLYCATE DISODIUM; LEVOCETIRIZINE; PLACEBO; PREDNISOLONE;

ADULT; ARTICLE; CAR DRIVING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NIGHT SLEEP; PARALLEL DESIGN; PERENNIAL RHINITIS; PHYSICAL ACTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SLEEP INDUCTION; SLEEP PARAMETERS; SLEEP WAKING CYCLE; SPORT; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; WORK CAPACITY;

EID: 33947197432     PISSN: 08381925     EISSN: None     Source Type: Journal    
DOI: 10.1027/0838-1925.19.1.4     Document Type: Article

References (21)

1. Gerth van Wijk R. Allergy: A global problem. Quality of life. Allergy 2002; 57:1097-1110
2. Holgate S, Powell R, Jenkins M, Ali O. A treatment for allergic rhinitis: A view on the role of levocetirizine. Curr Med Res Opin 2005; 21:1099-1106
3. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991; 21:77-83
4. Schipper H, Clinch J, Powell V. Definitions and conceptual issues. In B Spilker (Ed.), Quality of life assessment in clinical trials, New York: Raven Press, 1990, pp. 11-24
5. Fisher L, Ghaffari G, Davies M, Craig T. Effects of poor sleep in allergic rhinitis. Curr Opin Allergy Clin Immunol 2005; 5:11-16
6. Craig TJ, McCann JL, Gurevich F, Davies MJ. The correlation between allergic rhinitis and sleep disturbance. J Allergy Clin Immunol 2004; 114(5 Suppl):S139-145
7. Ferguson BJ. Influences of allergic rhinitis on sleep. Otolaryngol Head Neck Surg 2004; 130:617-629
8. Juniper EF, Rohrbaugh T, Meltzer EO. A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2003; 111:484-490
9. Bousquet J, Van Cauwenberge P, Khaltaev N; ARIA Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108: S147-S334
10. Bauchau V, Durham SR. Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy 2005; 60:350-353
11. Demoly P, Allaert F-A, Lecasble M, Bousquet J, PRAGMA. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy 2003; 58:672-675
12. Bachert C, Bousquet J, Canonica GW, Durham SR, Klimek L, Mullol J, Van Cauwenberge PB, Van Hammee G; XPERT Study Group. Levocetirizine improves quality-of-life and reduces costs in long term treatment of persistent allergic rhinitis. J Allergy Clin Immunol 2004; 114:838-844
13. Mullol J, C Bachert C, J Bousquet. Management of persistent allergic rhinitis: Evidence-based treatment with levocetirizine. Ther Clin Risk Manag 2005; 1:265-71
14. Shedden A. Impact of nasal congestion on quality of life and work productivity in allergic rhinitis: Findings from a large online survey. Treat Respir Med 2005; 4:439-46
15. Thompson AK, Juniper E, Meltzer EO. Quality of life in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2000; 85:338-347
16. Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ. Interpretation of Rhinoconjunctivitis Quality of Life Questionnaire data. J Allergy Clin Immunol 1996; 98:843-845
17. Ogino T, Ishii H, Abe Y, Imada M, Hayashi T, Nonaka S, Harabuchi Y. Analysis of risk factors for deficits in the quality of life in allergic rhinitis patients. Nippon Jibiinkoka Gakkai Kaiho 2005; 108:715-723
18. Downie SR, Andersson M, Rimmer J, Leuppi JD, Xuan W, Akerlund A, Peat JK, Salome CM. Symptoms of persistent allergic rhinitis during a full calendar year in house dust mite-sensitive subjects. Allergy 2004; 59:406-414
19. Mintz M, Garcia J, Diener P, Liao Y, Dupclay L, Georges G. Triamcinolone acetonide aqueous nasal spray improves nocturnal rhinitis-related quality of life in patients treated in a primary care setting: The Quality of Sleep in Allergic Rhinitis study. Ann Allergy Asthma Immunol 2004; 92:255-261
20. Hughes K, Glass C, Ripchinski M, Gurevich F, Weaver TE, Lehman E, Fisher LH, Craig TJ. Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis. Allergy 2003; 58:380-385
21. Gurevich F, Glass C, Davies M, Wei W, McCann J, Fisher L, Chegini S, Mende C, Craig T. Effect of intranasal steroid budesonide on the congestion-related sleep disturbance and daytime somnolence in patients with perennial allergic rhinitis. Allergy Asthma Proc 2005; 26:268-274